Literature DB >> 3278671

Axonal transport in neurological disease.

J W Griffin1, D F Watson.   

Abstract

The axonal transport systems have a wide variety of primary roles and secondary responses in neurological disease processes. Recent advances in understanding these roles have built on the increasingly detailed insights into the cell biology of the axon and its supporting cells. Fast transport is a microtubule-based system of bidirectional movement of membranous organelles; the mechanism of translocation of these organelles involves novel proteins, including the recently described protein of fast anterograde transport, kinesin. Slow transport conveys the major cytoskeletal elements, microtubules, and neurofilaments. Several types of structural changes in diseased nerve fibers are understood in terms of underlying transport abnormalities. Altered slow transport of neurofilaments produces changes in axonal caliber (swelling or atrophy) and is involved in some types of perikaryal neurofibrillary abnormality. Secondary changes in slow axonal transport--for example, the reordered synthesis and delivery of cytoskeletal proteins after axotomy--also can produce changes in axonal caliber. Secondary demyelination can be a prominent late consequence of a sustained alteration of neurofilament transport. Impaired fast transport is found in experimental models of distal axonal degeneration (dying back). Retrograde axonal transport provides access to the central nervous system for agents such as polio virus and tetanus toxin, as well as access for known and hypothetical trophic factors. Correlative studies of axonal transport, axonal morphometry, cytoskeletal ultrastructure, and molecular biology of cytoskeletal proteins are providing extremely detailed reconstructions of the pathogenesis of experimental models of neurological disorders. A major challenge lies in the extension of these approaches to clinical studies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278671     DOI: 10.1002/ana.410230103

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  38 in total

1.  A novel pathogenesis of megacolon in Ncx/Hox11L.1 deficient mice.

Authors:  M Hatano; T Aoki; M Dezawa; S Yusa; Y Iitsuka; H Koseki; M Taniguchi; T Tokuhisa
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Phosphorylated high molecular weight neurofilament protein in the peripheral motor, sensory and sympathetic neuronal perikarya: system-dependent normal variations and changes in amyotrophic lateral sclerosis and multiple system atrophy.

Authors:  T Itoh; G Sobue; E Ken; T Mitsuma; A Takahashi; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Therapeutic strategies for the inherited neuropathies.

Authors:  Michael E Shy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Lysosome trafficking and signaling in health and neurodegenerative diseases.

Authors:  Pearl P Y Lie; Ralph A Nixon
Journal:  Neurobiol Dis       Date:  2018-05-30       Impact factor: 5.996

5.  Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group.

Authors:  I S Martina; R van Koningsveld; P I Schmitz; F G van der Meché; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

6.  Association of aerobic glycolysis with the structural connectome reveals a benefit-risk balancing mechanism in the human brain.

Authors:  Yuhan Chen; Qixiang Lin; Xuhong Liao; Changsong Zhou; Yong He
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

Review 7.  Axonal transport disruption in peripheral nerve disease: From Jack's discoveries as a resident to recent contributions.

Authors:  Thomas E Lloyd
Journal:  J Peripher Nerv Syst       Date:  2012-12       Impact factor: 3.494

8.  Microstructural integrity of cerebral fiber tracts in hereditary spastic paraparesis with SPG11 mutation.

Authors:  M-K Pan; S-C Huang; Y-C Lo; Chih-Chao Yang; T-W Cheng; Chi-Cheng Yang; M-S Hua; M-J Lee; W-Y I Tseng
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-06       Impact factor: 3.825

Review 9.  Peripheral neuropathy and cancer.

Authors:  Arthur D Forman
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

10.  Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.

Authors:  T Ohshima; J M Ward; C G Huh; G Longenecker; H C Pant; R O Brady; L J Martin; A B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.